Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.cmet.2020.07.007 http://hdl.handle.net/11449/201151 |
Resumo: | COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals with uncontrolled glucose levels are more prone to develop the severe form of COVID-19. The molecular mechanism underlying SARS-CoV-2 infection and what determines the onset of the cytokine storm found in severe COVID-19 patients are unknown. Monocytes and macrophages are the most enriched immune cell types in the lungs of COVID-19 patients and appear to have a central role in the pathogenicity of the disease. These cells adapt their metabolism upon infection and become highly glycolytic, which facilitates SARS-CoV-2 replication. The infection triggers mitochondrial ROS production, which induces stabilization of hypoxia-inducible factor-1α (HIF-1α) and consequently promotes glycolysis. HIF-1α-induced changes in monocyte metabolism by SARS-CoV-2 infection directly inhibit T cell response and reduce epithelial cell survival. Targeting HIF-1ɑ may have great therapeutic potential for the development of novel drugs to treat COVID-19. Diabetic people with uncontrolled blood glucose levels have a greater risk to develop severe COVID-19 disease. Codo et al. show that elevated glucose levels and glycolysis promote SARS-CoV-2 (CoV-2) replication and cytokine production in monocytes through a mitochondrial ROS/hypoxia-inducible factor-1α dependent pathway, resulting in T cell dysfunction and epithelial cell death. |
id |
UNSP_b44b945b94c319f0da571d2453557519 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/201151 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent AxisCovid-19diabetesglycolysisHIF-1alphainflammationinterferonmetabolismmitochondriamonocyteSARS-CoV-2COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals with uncontrolled glucose levels are more prone to develop the severe form of COVID-19. The molecular mechanism underlying SARS-CoV-2 infection and what determines the onset of the cytokine storm found in severe COVID-19 patients are unknown. Monocytes and macrophages are the most enriched immune cell types in the lungs of COVID-19 patients and appear to have a central role in the pathogenicity of the disease. These cells adapt their metabolism upon infection and become highly glycolytic, which facilitates SARS-CoV-2 replication. The infection triggers mitochondrial ROS production, which induces stabilization of hypoxia-inducible factor-1α (HIF-1α) and consequently promotes glycolysis. HIF-1α-induced changes in monocyte metabolism by SARS-CoV-2 infection directly inhibit T cell response and reduce epithelial cell survival. Targeting HIF-1ɑ may have great therapeutic potential for the development of novel drugs to treat COVID-19. Diabetic people with uncontrolled blood glucose levels have a greater risk to develop severe COVID-19 disease. Codo et al. show that elevated glucose levels and glycolysis promote SARS-CoV-2 (CoV-2) replication and cytokine production in monocytes through a mitochondrial ROS/hypoxia-inducible factor-1α dependent pathway, resulting in T cell dysfunction and epithelial cell death.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundo de Apoio ao Ensino, à Pesquisa e Extensão, Universidade Estadual de CampinasConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Laboratory of Immunometabolism Department of Genetics Evolution Microbiology and Immunology Institute of Biology University of CampinasDepartment of Genetics Evolution Microbiology and Immunology Institute of Biology University of CampinasDepartment of Biochemistry and Tissue Biology Institute of Biology University of CampinasDepartment of Genetics at Ribeirao Preto Medical School University of Sao Paulo, Ribeirao PretoDepartment of Clinical and Toxicological analyses School of Pharmaceutical Sciences University of São PauloBrazilian Biosciences National Laboratory (LNBio), CampinasDepartment of Animal Biology Institute of Biology University of Campinas, CampinasDepartment of Internal Medicine School of Medical Sciences University of Campinas, CampinasDepartment of Clinical Medicine School of Medical Sciences University of Campinas, CampinasHematology and Hemotherapy Center University of Campinas, CampinasObesity and Comorbidities Research Center (OCRC) University of CampinasExperimental Medicine Research Cluster (EMRC) University of CampinasDepartment of Structural and Functional Biology Institute of Biosciences São Paulo State University (UNESP), BotucatuD'Or Institute for Research and Education (IDOR)Instituto Nacional de Biomarcadores em Neuropsiquiatria Conselho Nacional de Desenvolvimento Científico e TecnológicoDepartment of Structural and Functional Biology Institute of Biosciences São Paulo State University (UNESP), BotucatuFAPESP: 20/04579-7FAPESP: 2015/15626-8FAPESP: 2016/18031-8FAPESP: 2016/23328-0FAPESP: 2017/01184-9FAPESP: 2018/22505-0FAPESP: 2019/00098-7FAPESP: 2019/06372-3FAPESP: 2020/04522-5FAPESP: 2020/04558-0FAPESP: 2020/04583-4FAPESP: 2020/04746-0FAPESP: 2020/04919-2Fundo de Apoio ao Ensino, à Pesquisa e Extensão, Universidade Estadual de Campinas: 2274/20Universidade Estadual de Campinas (UNICAMP)Universidade de São Paulo (USP)Brazilian Biosciences National Laboratory (LNBio)Universidade Estadual Paulista (Unesp)D'Or Institute for Research and Education (IDOR)Conselho Nacional de Desenvolvimento Científico e TecnológicoCodo, Ana CamposDavanzo, Gustavo GastãoMonteiro, Lauar de Britode Souza, Gabriela FabianoMuraro, Stéfanie PrimonVirgilio-da-Silva, João VictorProdonoff, Juliana SilveiraCarregari, Victor Corasollade Biagi Junior, Carlos Alberto OliveiraCrunfli, FernandaJimenez Restrepo, Jeffersson LeandroVendramini, Pedro HenriqueReis-de-Oliveira, GuilhermeBispo dos Santos, KarinaToledo-Teixeira, Daniel A.Parise, Pierina LorenciniMartini, Matheus CavalheiroMarques, Rafael EliasCarmo, Helison R.Borin, AlexandreCoimbra, Laís DurçoBoldrini, Vinícius O.Brunetti, Natalia S.Vieira, Andre S.Mansour, EliUlaf, Raisa G.Bernardes, Ana F.Nunes, Thyago A.Ribeiro, Luciana C.Palma, Andre C.Agrela, Marcus V.Moretti, Maria LuizaSposito, Andrei C.Pereira, Fabrício BíscaroVelloso, Licio AugustoVinolo, Marco Aurélio RamirezDamasio, AndréProença-Módena, José LuizCarvalho, Robson Francisco [UNESP]Mori, Marcelo A.Martins-de-Souza, DanielNakaya, Helder I.Farias, Alessandro S.Moraes-Vieira, Pedro M.2020-12-12T02:25:21Z2020-12-12T02:25:21Z2020-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article437-446.e5http://dx.doi.org/10.1016/j.cmet.2020.07.007Cell Metabolism, v. 32, n. 3, p. 437-446.e5, 2020.1932-74201550-4131http://hdl.handle.net/11449/20115110.1016/j.cmet.2020.07.0072-s2.0-85088223490Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCell Metabolisminfo:eu-repo/semantics/openAccess2024-06-24T14:51:24Zoai:repositorio.unesp.br:11449/201151Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-06-24T14:51:24Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
title |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
spellingShingle |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis Codo, Ana Campos Covid-19 diabetes glycolysis HIF-1alpha inflammation interferon metabolism mitochondria monocyte SARS-CoV-2 |
title_short |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
title_full |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
title_fullStr |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
title_full_unstemmed |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
title_sort |
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis |
author |
Codo, Ana Campos |
author_facet |
Codo, Ana Campos Davanzo, Gustavo Gastão Monteiro, Lauar de Brito de Souza, Gabriela Fabiano Muraro, Stéfanie Primon Virgilio-da-Silva, João Victor Prodonoff, Juliana Silveira Carregari, Victor Corasolla de Biagi Junior, Carlos Alberto Oliveira Crunfli, Fernanda Jimenez Restrepo, Jeffersson Leandro Vendramini, Pedro Henrique Reis-de-Oliveira, Guilherme Bispo dos Santos, Karina Toledo-Teixeira, Daniel A. Parise, Pierina Lorencini Martini, Matheus Cavalheiro Marques, Rafael Elias Carmo, Helison R. Borin, Alexandre Coimbra, Laís Durço Boldrini, Vinícius O. Brunetti, Natalia S. Vieira, Andre S. Mansour, Eli Ulaf, Raisa G. Bernardes, Ana F. Nunes, Thyago A. Ribeiro, Luciana C. Palma, Andre C. Agrela, Marcus V. Moretti, Maria Luiza Sposito, Andrei C. Pereira, Fabrício Bíscaro Velloso, Licio Augusto Vinolo, Marco Aurélio Ramirez Damasio, André Proença-Módena, José Luiz Carvalho, Robson Francisco [UNESP] Mori, Marcelo A. Martins-de-Souza, Daniel Nakaya, Helder I. Farias, Alessandro S. Moraes-Vieira, Pedro M. |
author_role |
author |
author2 |
Davanzo, Gustavo Gastão Monteiro, Lauar de Brito de Souza, Gabriela Fabiano Muraro, Stéfanie Primon Virgilio-da-Silva, João Victor Prodonoff, Juliana Silveira Carregari, Victor Corasolla de Biagi Junior, Carlos Alberto Oliveira Crunfli, Fernanda Jimenez Restrepo, Jeffersson Leandro Vendramini, Pedro Henrique Reis-de-Oliveira, Guilherme Bispo dos Santos, Karina Toledo-Teixeira, Daniel A. Parise, Pierina Lorencini Martini, Matheus Cavalheiro Marques, Rafael Elias Carmo, Helison R. Borin, Alexandre Coimbra, Laís Durço Boldrini, Vinícius O. Brunetti, Natalia S. Vieira, Andre S. Mansour, Eli Ulaf, Raisa G. Bernardes, Ana F. Nunes, Thyago A. Ribeiro, Luciana C. Palma, Andre C. Agrela, Marcus V. Moretti, Maria Luiza Sposito, Andrei C. Pereira, Fabrício Bíscaro Velloso, Licio Augusto Vinolo, Marco Aurélio Ramirez Damasio, André Proença-Módena, José Luiz Carvalho, Robson Francisco [UNESP] Mori, Marcelo A. Martins-de-Souza, Daniel Nakaya, Helder I. Farias, Alessandro S. Moraes-Vieira, Pedro M. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual de Campinas (UNICAMP) Universidade de São Paulo (USP) Brazilian Biosciences National Laboratory (LNBio) Universidade Estadual Paulista (Unesp) D'Or Institute for Research and Education (IDOR) Conselho Nacional de Desenvolvimento Científico e Tecnológico |
dc.contributor.author.fl_str_mv |
Codo, Ana Campos Davanzo, Gustavo Gastão Monteiro, Lauar de Brito de Souza, Gabriela Fabiano Muraro, Stéfanie Primon Virgilio-da-Silva, João Victor Prodonoff, Juliana Silveira Carregari, Victor Corasolla de Biagi Junior, Carlos Alberto Oliveira Crunfli, Fernanda Jimenez Restrepo, Jeffersson Leandro Vendramini, Pedro Henrique Reis-de-Oliveira, Guilherme Bispo dos Santos, Karina Toledo-Teixeira, Daniel A. Parise, Pierina Lorencini Martini, Matheus Cavalheiro Marques, Rafael Elias Carmo, Helison R. Borin, Alexandre Coimbra, Laís Durço Boldrini, Vinícius O. Brunetti, Natalia S. Vieira, Andre S. Mansour, Eli Ulaf, Raisa G. Bernardes, Ana F. Nunes, Thyago A. Ribeiro, Luciana C. Palma, Andre C. Agrela, Marcus V. Moretti, Maria Luiza Sposito, Andrei C. Pereira, Fabrício Bíscaro Velloso, Licio Augusto Vinolo, Marco Aurélio Ramirez Damasio, André Proença-Módena, José Luiz Carvalho, Robson Francisco [UNESP] Mori, Marcelo A. Martins-de-Souza, Daniel Nakaya, Helder I. Farias, Alessandro S. Moraes-Vieira, Pedro M. |
dc.subject.por.fl_str_mv |
Covid-19 diabetes glycolysis HIF-1alpha inflammation interferon metabolism mitochondria monocyte SARS-CoV-2 |
topic |
Covid-19 diabetes glycolysis HIF-1alpha inflammation interferon metabolism mitochondria monocyte SARS-CoV-2 |
description |
COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals with uncontrolled glucose levels are more prone to develop the severe form of COVID-19. The molecular mechanism underlying SARS-CoV-2 infection and what determines the onset of the cytokine storm found in severe COVID-19 patients are unknown. Monocytes and macrophages are the most enriched immune cell types in the lungs of COVID-19 patients and appear to have a central role in the pathogenicity of the disease. These cells adapt their metabolism upon infection and become highly glycolytic, which facilitates SARS-CoV-2 replication. The infection triggers mitochondrial ROS production, which induces stabilization of hypoxia-inducible factor-1α (HIF-1α) and consequently promotes glycolysis. HIF-1α-induced changes in monocyte metabolism by SARS-CoV-2 infection directly inhibit T cell response and reduce epithelial cell survival. Targeting HIF-1ɑ may have great therapeutic potential for the development of novel drugs to treat COVID-19. Diabetic people with uncontrolled blood glucose levels have a greater risk to develop severe COVID-19 disease. Codo et al. show that elevated glucose levels and glycolysis promote SARS-CoV-2 (CoV-2) replication and cytokine production in monocytes through a mitochondrial ROS/hypoxia-inducible factor-1α dependent pathway, resulting in T cell dysfunction and epithelial cell death. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-12T02:25:21Z 2020-12-12T02:25:21Z 2020-09-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.cmet.2020.07.007 Cell Metabolism, v. 32, n. 3, p. 437-446.e5, 2020. 1932-7420 1550-4131 http://hdl.handle.net/11449/201151 10.1016/j.cmet.2020.07.007 2-s2.0-85088223490 |
url |
http://dx.doi.org/10.1016/j.cmet.2020.07.007 http://hdl.handle.net/11449/201151 |
identifier_str_mv |
Cell Metabolism, v. 32, n. 3, p. 437-446.e5, 2020. 1932-7420 1550-4131 10.1016/j.cmet.2020.07.007 2-s2.0-85088223490 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Cell Metabolism |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
437-446.e5 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1826303542371024896 |